BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 20013553)

  • 1. Prescribing a sedative antidepressant for patients at work or on sick leave under conditions of routine care.
    Linden M; Westram A
    Pharmacopsychiatry; 2010 Jan; 43(1):1-6. PubMed ID: 20013553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depressed in-patients respond differently to imipramine and mirtazapine.
    Bruijn JA; Moleman P; Mulder PG; van den Broek WW
    Pharmacopsychiatry; 1999 May; 32(3):87-92. PubMed ID: 10463374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of ankylosing spondylitis on sick leave, presenteeism and unpaid productivity, and estimation of the societal cost.
    Boonen A; Brinkhuizen T; Landewé R; van der Heijde D; Severens JL
    Ann Rheum Dis; 2010 Jun; 69(6):1123-8. PubMed ID: 20439293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with variability in length of sick leave because of acute low back pain in Chile.
    Diaz-Ledezma C; Urrutia J; Romeo J; Chelen A; González-Wilhelm L; Lavarello C
    Spine J; 2009 Dec; 9(12):1010-5. PubMed ID: 19837008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antidepressants consumption in the global population in France].
    Olié JP; Elomari F; Spadone C; Lépine JP
    Encephale; 2002; 28(5 Pt 1):411-7. PubMed ID: 12386542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sick leave and depression - determining factors and clinical effect in outpatient care.
    Bermejo I; Kriston L; Schneider F; Gaebel W; Hegerl U; Berger M; Härter M
    Psychiatry Res; 2010 Dec; 180(2-3):68-73. PubMed ID: 20494453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Working conditions predict incidence of long-term spells of sick leave due to depression: results from the Belstress I prospective study.
    Clumeck N; Kempenaers C; Godin I; Dramaix M; Kornitzer M; Linkowski P; Kittel F
    J Epidemiol Community Health; 2009 Apr; 63(4):286-92. PubMed ID: 19126562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression.
    Malhi GS; Ng F; Berk M
    Aust N Z J Psychiatry; 2008 Apr; 42(4):346-9. PubMed ID: 18330778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mirtazapine orally disintegrating tablet versus sertraline: a prospective onset of action study.
    Behnke K; Søgaard J; Martin S; Bäuml J; Ravindran AV; Agren H; Vester-Blokland ED
    J Clin Psychopharmacol; 2003 Aug; 23(4):358-64. PubMed ID: 12920411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mirtazapine: a newer antidepressant.
    Hartmann PM
    Am Fam Physician; 1999 Jan; 59(1):159-61. PubMed ID: 9917581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parental availability for the care of sick children.
    Heymann SJ; Earle A; Egleston B
    Pediatrics; 1996 Aug; 98(2 Pt 1):226-30. PubMed ID: 8692622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of an activating intervention by social workers for patients with minor mental disorders on sick leave: a randomized controlled trial.
    Brouwers EP; de Bruijne MC; Terluin B; Tiemens BG; Verhaak PF
    Eur J Public Health; 2007 Apr; 17(2):214-20. PubMed ID: 16837516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What do psychiatrists talk about with their depressed patients parallel to prescribing an antidepressant?
    Linden M; Westram A
    Int J Psychiatry Clin Pract; 2011 Mar; 15(1):35-41. PubMed ID: 22122687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific job anxiety in comparison to general psychosomatic symptoms at admission, discharge and six months after psychosomatic inpatient treatment.
    Muschalla B; Linden M
    Psychopathology; 2012; 45(3):167-73. PubMed ID: 22398433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Work and sick leave among patients with early inflammatory joint conditions.
    Geuskens GA; Hazes JM; Barendregt PJ; Burdorf A
    Arthritis Rheum; 2008 Oct; 59(10):1458-66. PubMed ID: 18821663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between mirtazapine dose, plasma concentration, response, and side effects in clinical practice.
    Grasmäder K; Verwohlt PL; Kühn KU; Frahnert C; Hiemke C; Dragicevic A; von Widdern O; Zobel A; Maier W; Rao ML
    Pharmacopsychiatry; 2005 May; 38(3):113-7. PubMed ID: 15902580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What works best for whom? An exploratory, subgroup analysis in a randomized, controlled trial on the effectiveness of a workplace intervention in low back pain patients on return to work.
    Steenstra IA; Knol DL; Bongers PM; Anema JR; van Mechelen W; de Vet HC
    Spine (Phila Pa 1976); 2009 May; 34(12):1243-9. PubMed ID: 19412140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mirtazapine vs. amitriptyline vs. placebo in the treatment of major depressive disorder.
    Smith WT; Glaudin V; Panagides J; Gilvary E
    Psychopharmacol Bull; 1990; 26(2):191-6. PubMed ID: 2236455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A meta-analysis of eight randomized, double-blind, controlled clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety.
    Fawcett J; Barkin RL
    J Clin Psychiatry; 1998 Mar; 59(3):123-7. PubMed ID: 9541155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, double-blind, 24-week study comparing the efficacy and tolerability of mirtazapine and paroxetine in depressed patients in primary care.
    Wade A; Crawford GM; Angus M; Wilson R; Hamilton L
    Int Clin Psychopharmacol; 2003 May; 18(3):133-41. PubMed ID: 12702891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.